Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Liabilities from Discontinued Operations of 7073000.0 for Q4 2025, down 20.57% year-on-year from 8905000.0 in Q4 2024, and down 20.57% on a QoQ basis from 8905000.0 in Q4 2024.

Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Liabilities from Discontinued Operations for 6 consecutive years, with 7073000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Liabilities from Discontinued Operations fell 20.57% year-over-year to 7073000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 7073000.0 (down 20.57% YoY) and the FY2025 annual result came in at 7073000.0, down 20.57% from the prior year.
  • Liabilities from Discontinued Operations fell to 7073000.0 in Q4 2025 per CURLF's latest filing, from 8905000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for CURLF reached as high as 23045000000.0 in Q1 2022 and fell as low as 1067000.0 in Q3 2024.
  • A 5-year average of 1549350066.67 and a median of 12775000.0 in 2021 frame the typical range for Liabilities from Discontinued Operations.
  • Annual changes were most pronounced in 2022 — Liabilities from Discontinued Operations jumped 180291.39% — and 2024, when it plunged 95.67%.
  • Year by year, Liabilities from Discontinued Operations stood at 18581000.0 in 2021, then surged by 91.3% to 35545000.0 in 2022, then slumped by 74.19% to 9173000.0 in 2023, then slipped by 2.92% to 8905000.0 in 2024, then declined by 20.57% to 7073000.0 in 2025.
  • According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 7073000.0, 8905000.0, and 1067000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.07 Mn
Dec 31, 2025 7.07 Mn
Dec 31, 2024 8.91 Mn
Dec 31, 2024 8.91 Mn
Sep 30, 2024 1.07 Mn
Sep 30, 2024 1.07 Mn
Jun 30, 2024 3.00 Mn
Jun 30, 2024 3.00 Mn
Dec 31, 2023 9.17 Mn
Dec 31, 2023 9.17 Mn
Sep 30, 2023 24.62 Mn
Sep 30, 2023 24.62 Mn
Jun 30, 2023 10.51 Mn
Jun 30, 2023 10.51 Mn
Dec 31, 2022 35.55 Mn
Dec 31, 2022 35.55 Mn
Sep 30, 2022 15.83 Mn
Sep 30, 2022 15.83 Mn
Jun 30, 2022 18.85 Mn
Jun 30, 2022 18.85 Mn